An inhibition enzyme immunoassay for myelin basic protein
N P Groome1, J Harland, J Appleby
1Biology Department, Oxford Polytechnic, Headington, Oxford OX3 0BP, U.K.
Neurochemistry International
|May 22, 2010
Summary
This study presents an improved Enzyme Immunoassay for Myelin Basic Protein (MBP). The assay offers a sensitive and stable method for detecting MBP in various samples, requiring minimal equipment.
Area of Science:
- Neuroimmunology
- Biochemistry
- Analytical Chemistry
Background:
- Myelin Basic Protein (MBP) is a key component of myelin sheath.
- Accurate quantification of MBP is crucial for understanding neurological disorders.
Purpose of the Study:
- To develop and validate an improved Enzyme Immunoassay (EIA) for Myelin Basic Protein (MBP).
- To assess the assay's sensitivity, stability, and applicability to different biological samples.
Main Methods:
- A competitive Enzyme Immunoassay format was developed using MBP-coated glass balls and a peroxidase-conjugated anti-MBP antibody.
- The assay measures the inverse relationship between bound peroxidase activity and MBP concentration in samples.
Main Results:
- The assay demonstrated a detection limit of 0.6 ng/ml for diluent and spinal fluid.
- For plasma samples, a dilution step yielded a detection limit of 1.8 ng/ml.
- Both coated balls and peroxidase conjugate exhibited long-term stability, and the assay requires no expensive equipment.
Conclusions:
- The developed EIA is a sensitive, stable, and cost-effective method for MBP quantification.
- The assay is suitable for analyzing subcellular fractions, spinal fluid, and plasma.
- Further optimization with specific antisera or monoclonal antibodies may enhance detection in complex clinical samples.
